GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kezar Life Sciences Inc (FRA:2KZ) » Definitions » Current Accrued Expense

Kezar Life Sciences (FRA:2KZ) Current Accrued Expense : €4.44 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kezar Life Sciences Current Accrued Expense?

Kezar Life Sciences's Current Accrued Expense for the quarter that ended in Mar. 2024 was €4.44 Mil.

Kezar Life Sciences's quarterly Current Accrued Expense declined from Sep. 2023 (€7.21 Mil) to Dec. 2023 (€2.45 Mil) but then increased from Dec. 2023 (€2.45 Mil) to Mar. 2024 (€4.44 Mil).

Kezar Life Sciences's annual Current Accrued Expense declined from Dec. 2021 (€2.58 Mil) to Dec. 2022 (€2.29 Mil) but then increased from Dec. 2022 (€2.29 Mil) to Dec. 2023 (€2.45 Mil).


Kezar Life Sciences Current Accrued Expense Historical Data

The historical data trend for Kezar Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kezar Life Sciences Current Accrued Expense Chart

Kezar Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial 2.49 1.23 2.58 2.29 2.45

Kezar Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 5.87 7.21 2.45 4.44

Kezar Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Kezar Life Sciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kezar Life Sciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Kezar Life Sciences (FRA:2KZ) Business Description

Traded in Other Exchanges
Address
4000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Kezar Life Sciences (FRA:2KZ) Headlines

No Headlines